Showing results (1-10 of 342) with videos related to
Sort By:
Pageof 35
Frontiers in Pharmacology|March 29, 2021
Multi-Target Approaches in Metabolic SyndromeFelix F Lillich, John D Imig, Ewgenij ProschakDiabetologia|July 23, 2018
A novel dual PPAR-γ agonist/sEH inhibitor treats diabetic complications in a rat model of type 2 diabetesMd Abdul Hye Khan, Lauren Kolb, Melissa Skibba, et al.Prostaglandins & Other Lipid Mediators|July 22, 2017
Phosphatase activity of soluble epoxide hydrolaseJan Kramer, Ewgenij ProschakJournal of Medicinal Chemistry|April 1, 2021
Oxaprozin Analogues as Selective RXR Agonists with Superior Properties and PharmacokineticsSimone Schierle, Apirat Chaikuad, Felix F Lillich, et al.ACS Medicinal Chemistry Letters|April 16, 2025
Fragment-Based Discovery of Drug-like LRH-1 AgonistsAlisa Lang, Niklas Ildefeld, Felix F Lillich, et al.Molecular Informatics|July 29, 2016
Structure-Based Pharmacophores for Virtual ScreeningMartin Löwer, Ewgenij ProschakExpert Opinion on Therapeutic Patents|June 16, 2012
5-Lipoxygenase inhibitors: a patent evaluation (WO2011161615)Estel la Buscató, Ewgenij ProschakChemistry Central Journal|September 21, 2007
PocketPicker: analysis of ligand binding-sites with shape descriptorsMartin Weisel, Ewgenij Proschak, Gisbert SchneiderJournal of Medicinal Chemistry|July 24, 2018
Polypharmacology by Design: A Medicinal Chemist's Perspective on Multitargeting CompoundsEwgenij Proschak, Holger Stark, Daniel MerkJournal of Chemical Information and Modeling|November 8, 2007
Kernel approach to molecular similarity based on iterative graph similarityMatthias Rupp, Ewgenij Proschak, Gisbert SchneiderPageof 35